Subscribe To
Spc nickel reports positive new assay results from west graham drilling
SPC Nickel Corp (TSX-V:SPC, OTC:SPCNF) revealed positive new assay results from its phase 1 drilling ca...
April 26, 2023, 9:27 am
Usdjpy challenges april’s bullish trend
USDJPY has been in a slow corrective mode below the 135.00 area so far this week, making investors wonder whether this is another temporary bearish ...
April 26, 2023, 8:25 am
Soft guidance shouldn't take the shine off enphase energy stock
Enphase Energy, Inc. (NASDAQ: ENPH) stock is down 16% in after-hours trading after concerns about softe...
April 26, 2023, 7:19 am
Enphase revenue and profits soar as guidance disappoints
Enphase (NASDAQ: ENPH), the giant energy technology company, announced stronger-than-expected results. ...
April 26, 2023, 7:16 am
Morphic: positive phase 2a uc trial, top m&a candidate in 2023
Morphic: Positive phase 2a UC Trial, Top M&A Candidate In 2023....
April 25, 2023, 10:20 pm
Earnings results: enphase stock falls more than 15% as energy-tech company’s revenue outlook comes up short
Enphase Energy Inc. stock drops more than 15% Tuesday after the energy company reports quarterly earnin...
April 25, 2023, 9:45 pm
Enphase stock falls more than 14% after disappointing revenue outlook
Enphase stock falls more than 14% after disappointing revenue outlook Read Full Story The post En...
April 25, 2023, 8:36 pm
Enphase energy, inc. (enph) q1 2023 earnings call transcript
Enphase Energy, Inc. (ENPH) Q1 2023 Earnings Call Transcript....
April 25, 2023, 7:02 pm
Lcid stock alert: lucid gravity suv hits the roads for testing
Though the electric vehicle (EV) sector generated news for the wrong reasons lately, Lucid Group (NASDAQ: LCID ) sparked some forward-looking optimism...
April 25, 2023, 2:30 pm
Btc/usd: bullish engulfing pattern above $26,981
Bitcoin continues its bullish momentum from last week, and after touching a low of $26,981 on April 24, we can see a move towards a consolidation phas...
April 25, 2023, 1:44 pm
Delta resources stock jumps on gold drill results
Delta Resources Limited (TSX-V:DLTA) (TSXV:DLTA) shares gained 10% to $0.54 on Tuesday after the Canadian mineral exploration company provided assay ...
April 25, 2023, 1:01 pm
Virios therapeutics up 75% on fibromyalgia phase 3 proposal
Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromya...
April 25, 2023, 11:30 am
Arrowhead pharmaceuticals shares rise on positive interim trial results
Arrowhead Pharmaceuticals has released positive interim results from its phase 1/2 study of its investi...
April 25, 2023, 11:07 am
Virios therapeutics stock doubles as fibromyalgia program moves forward
Virios Therapeutics shares more than doubled after the biotechnology company announced that its proposed phase...
April 25, 2023, 10:48 am
Why is virios therapeutics (viri) stock up 92% today?
Virios Therapeutics (NASDAQ: VIRI ) stock is rocketing higher on Tuesday following an update on its planned p...
April 25, 2023, 8:01 am
Okyo pharma ready to kick off dry eye trial in the us
OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO), an ophthalmology-focused biotech, said has activated its first clinical trial site in the United States for ...
April 25, 2023, 2:28 am
Baudax bio to host key opinion leader webinar to discuss results of phase 2 bx1000 trial
Virtual Webinar to be held April 25, 2023 at 10:00 AM Eastern Time MALVERN, Pa., April 24, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (Nasdaq:BXRX) (t...
April 24, 2023, 8:30 pm
Disney begins second round of layoffs with more on the way. should investors be worried?
Disney has announced the second phase of its planned layoffs. This is all part of a previously announce...
April 24, 2023, 4:01 pm
Ideaya biosciences shares jump on melanoma interim trial results
IDEAYA Biosciences shares jumped after the company posted additional positive interim results from its phase <...
April 24, 2023, 12:27 pm
Biorestorative therapies announces completion of patient enrollment for safety run-in component of its phase 2 clinical study of brtx-100
—Clinical data from safety run-in scheduled to be released in second half of 2023.— MELVILLE, N.Y., April 24, 2023 (GLOBE NEWSWIRE) — BioRestora...
April 24, 2023, 11:00 am